News
Sexual wellness start-up bags US$1.2m investment
Founder Lyndsey Harper aims to empower women to talk about sexual health issues
The US sexual wellness start-up Rosy has bagged a US$1.2m investment to “revolutionise” sexual health education.
Rosy, a sexual wellness-focused app and media platform led by CEO and founder Dr Lyndsey Harper, aims to grant women access to information and interventions to solve their sexual health problems.
A board-certified OB/GYN, Harper started Rosy after recognising that 43 per cent of women had a sexual health problem but were met with a complete lack of resources when trying to solve these important issues.
She launched the platform in 2019 with the goal of putting sexual health education and tools in the hands of women everywhere.
As of February, more than eight per cent of OB/GYNs across the US are referring patients to Rosy, which serves around 150,000 women.
“Rosy has redefined the landscape of women’s sexual health. We’re now expanding into B2B partnerships that will allow us to take this mission even further,” said Harper.
“Rosy’s data set is likely the largest in the field of women’s sexual health and we will use the power of these solutions to create an even more robust experience for our members and partners beyond what we could have imagined a few years ago.”
The company will use the fresh funding to extend its reach into other areas of women’s health and explore various partnerships.
Its founder has previously said she created Rosy with the aim to “revolutionise” the way women and their providers think about, talk about, and treat women’s sexual problems.
“For men, sexual health and overall health have always been linked. At Rosy, our goal is to finally treat women’s sexual health as a crucial aspect of their overall wellbeing,” Harper said.
“It’s time women feel empowered to talk about sexual health issues and have access to convenient solutions.”
Opinion
The science behind the scar: What’s really in our period products
By Ruby Raut, founder and CEO, WUKA
Over the past year, headlines about “toxic period products” have been hard to ignore. Stories about PFAS, heavy metals, and hormone disruptors in pads, tampons, and underwear have sparked global concern, and for good reason. But behind the fear, there’s a scientific story worth understanding.
At the recent House of Lords event, “Have We Reached the Tipping Point for Toxic Period Products?”, researchers and policymakers came together to separate fact from panic. The truth is more nuanced: yes, chemicals and metals are present in some menstrual products, but understanding how much, where they come from, and what that means for our health is key to driving change that’s informed, not sensational.
What Scientists Have Found So Far
Dr Kathrin Schilling, an environmental health scientist at Columbia University, shared new research that tested 16 metals in menstrual products, including arsenic, cadmium, lead, and antimony, all known toxic substances linked to long-term health effects such as cardiovascular disease, kidney problems, and hormonal disruption.
The findings were striking:
- Non-organic products showed higher levels of lead and cadmium than organic ones.
- Some reusable and single-use products exceeded 30,000 nanograms per gram (ng/g) of antimony, a toxic metal commonly used in plastics manufacturing.
- Lead levels varied dramatically, some products contained 100× more than others.
To put this in perspective, even very small doses of lead can cause harm. The World Health Organization confirms there is no safe level of lead exposure. Chronic, low-level contact can gradually affect the nervous system and fertility. The same applies to arsenic, where countries have tightened drinking water limits from 10 µg/L to as low as 1 µg/L after learning that long-term exposure causes disease.
So while the numbers in menstrual products might sound tiny, what matters most is frequency and route of exposure. Menstrual products are used regularly and in contact with one of the body’s most absorbent tissues — the vaginal wall — where absorption is estimated to be 10–80× higher than through skin. Over decades of use, even low concentrations can add up.
Understanding PFAS — The “Forever Chemicals”
Alongside metals, PFAS (per- and polyfluoroalkyl substances) have become another major concern. These synthetic compounds are used for absorbency and stain resistance — but they don’t break down easily, earning the name “forever chemicals.”
They accumulate in soil, water, and the human body, and have been linked to reproductive issues, thyroid disease, and immune dysfunction. California recently became the first state to ban PFAS in menstrual products, while New York is pushing for broader restrictions that include heavy metals and hormone disruptors.
These international shifts signal a clear message: the world is moving towards stricter, transparency-first regulation — something the UK could soon follow.
Why It Matters for Our Bodies
It’s important to remember that our world is already filled with background exposure, from air pollution, processed food, and household plastics. We all live in a chemically complex environment. The key isn’t to fear every product but to understand which exposures matter most and how to minimise them.
Menstrual products are unique because of their intimate and repeated contact with the body. Even trace chemicals can bypass the body’s natural detox systems when absorbed vaginally. This doesn’t mean every product is dangerous, but it underscores why regular, independent testing and clear ingredient disclosure are essential.
Internal vs. External Exposure: Why It Makes a Difference
One of the least understood parts of this debate is the difference between internal and external products. A pad or period underwear sits on the skin; it can only transfer chemicals through surface contact. But products like tampons or menstrual cups are inserted directly into the vagina, an environment that absorbs substances 10–80 times more efficiently than normal skin.
That’s because the vaginal wall is highly vascular, full of small blood vessels, and it bypasses the liver, the organ that usually filters and detoxifies harmful substances. So when a chemical is absorbed vaginally, it goes straight into the bloodstream.
Yet, most testing and regulation still treat all menstrual products as if exposure happens through skin contact. There’s very little research separating the risk profiles of internal (tampons, cups, discs) versus external (pads, underwear) products. That’s why scientists like Dr Schilling emphasised the need for new safety standards that actually reflect how the body interacts with these materials, not just how a fabric performs in a laboratory test.
How Responsible Brands Are Responding
Some brands are already ahead of regulation.
At WUKA, we take this responsibility seriously. We are one of the very few period underwear brands with no PFAS detected in our products. Every batch is tested rigorously, both at source (in China) and again in the UK by Eurofins laboratories, an independent global testing agency.
We also screen for toxic chemicals, metals, and harmful finishes, ensuring that what touches your body is as safe as it is sustainable. As a founder, I always remind our team: I use our products myself. If I wouldn’t wear it, I wouldn’t make it for anyone else.
Our philosophy is simple, transparency builds trust. Consumers shouldn’t need a chemistry degree to choose a safe period product.
The Path Ahead
The science is clear: menstrual product safety deserves the same rigour as drinking water, cosmetics, or food. But we can also take heart, awareness is growing, data is expanding, and governments are beginning to act.
As policymakers push for international standards (through bodies like the ISO TC338 on menstrual products), and as responsible brands lead by example, the future of menstrual care looks safer, smarter, and far more transparent than the past.
This isn’t just about fear of toxins, it’s about empowering everyone who menstruates with knowledge and choice. Because understanding the science is the first step toward changing it.
Find out more about WUKA at wuka.co.uk
Insight
Women face worse stroke recovery than men in first year, study finds
Insight
Caesarean births overtake natural vaginal deliveries in England for first time
Caesarean births (surgical births) have overtaken vaginal deliveries in England for the first time, with 45 per cent of births now by caesarean, NHS data show.
Last year, 44 per cent of births were through natural vaginal deliveries and 11 per cent were assisted with instruments such as forceps or ventouse, according to data published on Tuesday covering April 2024 to March 2025. Assisted deliveries use instruments to help the baby out during birth.
More than four in ten caesareans carried out by NHS England were elective, planned operations. For women under 30, natural vaginal birth remained the most common method, while for women aged 30 and over, caesareans were most common. For women aged 40 and over, 59 per cent of births were by caesarean.
In total, 20 per cent of births in 2024-25 were planned caesareans and 25.1 per cent were emergency, with both figures at record highs.
There were 542,235 deliveries in NHS England hospitals during this period, down from 636,643 in 2014-15. One in four births were to mothers aged over 35.
In 2014-15, caesarean deliveries made up 26.5 per cent of births. The increase over the past decade has been attributed to growing numbers of complex pregnancies, linked to factors including rising obesity rates and women waiting until they are older to have children.
Donna Ockenden, one of the UK’s most senior midwives who is leading the inquiry into maternity failures in Nottingham, told BBC Radio 4’s Today programme that the rise was a “complex” and “evolving picture over time”.
She said: “The thousands of women I’ve spoken to want a safe birth above everything else, so we should not vilify or criticise women who make those decisions.”
“In the reality of today’s maternity services – where women are living in poverty, deprivation, they’ve got pre-existing illnesses – obstetricians, midwives, nurses can only do so much, and we don’t always do enough in all cases to optimise women’s health prior to pregnancy.”
Soo Downe, a professor of midwifery at the University of Lancashire, added: “In some cases women are going for caesarean sections as a kind of least-worst option because they don’t really believe they’re going to have the kind of support they need to have a safe, straightforward, positive labour and birth in hospital.
“Or because their birth centres are being closed … or because they go into labour wanting a home birth and the midwife isn’t able to come to them because the midwife’s called somewhere else.
“But for some of them, it becomes the only choice on the table … and for other women, they choose a caesarean because they really want one, and that’s absolutely fine.”
-
Features1 week agoCannabis compounds kill ovarian cancer without harming healthy cells, research finds
-
Insight3 weeks agoFemtech in 2025: A year of acceleration, and what data signals for 2026
-
Entrepreneur4 weeks agoInnovate UK relaunches £4.5m women founders programme
-
News4 weeks agoDoctors push back on ‘data-free’ ruling on menopause hormone therapy
-
Insight2 weeks agoMeta removes dozens of abortion advice and queer advocacy accounts
-
Opinion4 weeks agoWhy women’s health tech is crucial in bridging the gender health gap
-
News3 weeks agoRound up: First wearable detects symptoms of perimenopause, and more
-
Insight2 weeks agoSperm donor with cancer-causing gene fathered nearly 200 children across Europe






1 Comment